What does APOTHEEK REYNAERTS do?

APOTHEEK REYNAERTS is a logistics company in Scherpenheuvel-Zichem. Public Limited, started on 29 November 1984, 1 establishment.

What is the address of APOTHEEK REYNAERTS?

The registered office of APOTHEEK REYNAERTS is located at Westelsebaan 61B, 3271 Scherpenheuvel-Zichem.

Is APOTHEEK REYNAERTS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK REYNAERTS is active, legal situation “Normale toestand”, started on 29 November 1984.

Is APOTHEEK REYNAERTS registered on Peppol?

Yes, APOTHEEK REYNAERTS is registered on the Peppol network with ID 0208:0426518007.

What is the enterprise number of APOTHEEK REYNAERTS?

The enterprise number of APOTHEEK REYNAERTS is BE0426518007.

When was APOTHEEK REYNAERTS founded?

APOTHEEK REYNAERTS was founded on 29 November 1984.

Who are the directors of APOTHEEK REYNAERTS?

According to the 2025 annual accounts, the directors of APOTHEEK REYNAERTS are: CHRISTINE LAENEN, J.M.C. MANAGEMENT NV.

Is APOTHEEK REYNAERTS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 November 1984; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK REYNAERTS make in 2025?

APOTHEEK REYNAERTS posted a profit after taxes of € 142,718 in financial year 2025.

What is the revenue of APOTHEEK REYNAERTS?

As a small company, APOTHEEK REYNAERTS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 272,853.

How much does an employee at APOTHEEK REYNAERTS earn?

The average wage cost per full-time employee at APOTHEEK REYNAERTS was € 49,800 in 2025: staff costs of € 84,585 for 1.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK REYNAERTS have?

According to the 2025 annual accounts, APOTHEEK REYNAERTS has 1.7 full-time equivalents (FTE).

APOTHEEK REYNAERTS (Public Limited) - Scherpenheuvel-Zichem

Dossier APOTHEEK REYNAERTS, printed on 30 October 2026 from databakkes.be/en/0426518007/apotheek-reynaerts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK REYNAERTS from Scherpenheuvel-Zichem, company number BE0426518007, closed financial year 2025 with a result of € 142,718 after tax. For that financial year APOTHEEK REYNAERTS recorded a gross margin of € 272,853 and equity of € 238,815. Compared with financial year 2024, the result moved from € 80,946 to € 142,718. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 238,815

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 142,718

▲ 76% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 395,029

▲ 51% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 142,700 paid out

100 % of the profit went to the shareholders, mostly to J.M.C. MANAGEMENT (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 84,585

▲ 7% vs 2024

€ 49,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 13,061

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 31,382

▼ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,434

▼ 17% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 252,860 Gross margin 2022: € 252,860 First fiscal year in the series	€ 244,621 Gross margin 2023: € 244,621 ▼ 3% vs 2022 (€ 252,860) Unfavourable step	€ 203,807 Gross margin 2024: € 203,807 ▼ 17% vs 2023 (€ 244,621) Unfavourable step	€ 272,853 Gross margin 2025: € 272,853 ▲ 34% vs 2024 (€ 203,807) Favourable step	▲ 34%
Profit after taxes	€ 164,239 Profit after taxes 2022: € 164,239 First fiscal year in the series	€ 141,242 Profit after taxes 2023: € 141,242 ▼ 14% vs 2022 (€ 164,239) Unfavourable step	€ 80,946 Profit after taxes 2024: € 80,946 ▼ 43% vs 2023 (€ 141,242) Unfavourable step	€ 142,718 Profit after taxes 2025: € 142,718 ▲ 76% vs 2024 (€ 80,946) Favourable step	▲ 76%
Equity	€ 238,710 Equity 2022: € 238,710 First fiscal year in the series	€ 238,751 Equity 2023: € 238,751 Unchanged (€ 238,710) Favourable step	€ 238,798 Equity 2024: € 238,798 Unchanged (€ 238,751) Favourable step	€ 238,815 Equity 2025: € 238,815 Unchanged (€ 238,798) Favourable step
Total debts	€ 426,934 Total debts 2022: € 426,934 First fiscal year in the series	€ 579,912 Total debts 2023: € 579,912 ▲ 36% vs 2022 (€ 426,934) Unfavourable step	€ 294,083 Total debts 2024: € 294,083 ▼ 49% vs 2023 (€ 579,912) Favourable step	€ 438,424 Total debts 2025: € 438,424 ▲ 49% vs 2024 (€ 294,083) Unfavourable step	▲ 49%
Cash	€ 307,262 Cash 2022: € 307,262 First fiscal year in the series	€ 383,055 Cash 2023: € 383,055 ▲ 25% vs 2022 (€ 307,262) Favourable step	€ 261,548 Cash 2024: € 261,548 ▼ 32% vs 2023 (€ 383,055) Unfavourable step	€ 395,029 Cash 2025: € 395,029 ▲ 51% vs 2024 (€ 261,548) Favourable step	▲ 51%
Land & buildings	€ 158,250 Land & buildings 2022: € 158,250 First fiscal year in the series	€ 145,500 Land & buildings 2023: € 145,500 ▼ 8% vs 2022 (€ 158,250) Unchanged	€ 132,750 Land & buildings 2024: € 132,750 ▼ 9% vs 2023 (€ 145,500) Unchanged	€ 120,000 Land & buildings 2025: € 120,000 ▼ 10% vs 2024 (€ 132,750) Unchanged	▼ 10%
Retained profit	€ 176,710 Retained profit 2022: € 176,710 First fiscal year in the series	€ 176,751 Retained profit 2023: € 176,751 Unchanged (€ 176,710) Favourable step	€ 176,798 Retained profit 2024: € 176,798 Unchanged (€ 176,751) Favourable step	€ 176,815 Retained profit 2025: € 176,815 Unchanged (€ 176,798) Favourable step
Dividend	€ 160,000 Dividend 2022: € 160,000 First fiscal year in the series	€ 141,200 Dividend 2023: € 141,200 ▼ 12% vs 2022 (€ 160,000) Unchanged	€ 80,900 Dividend 2024: € 80,900 ▼ 43% vs 2023 (€ 141,200) Unchanged	€ 142,700 Dividend 2025: € 142,700 ▲ 76% vs 2024 (€ 80,900) Unchanged	▲ 76%
Balance sheet total	€ 665,644 Balance sheet total 2022: € 665,644 First fiscal year in the series	€ 818,664 Balance sheet total 2023: € 818,664 ▲ 23% vs 2022 (€ 665,644) Unchanged	€ 532,880 Balance sheet total 2024: € 532,880 ▼ 35% vs 2023 (€ 818,664) Unchanged	€ 677,239 Balance sheet total 2025: € 677,239 ▲ 27% vs 2024 (€ 532,880) Unchanged	▲ 27%
Employees (FTE)	1.7 Employees (FTE) 2022: 1.7 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 Unchanged (1.7) Unchanged	1.7 Employees (FTE) 2024: 1.7 Unchanged (1.7) Unchanged	1.7 Employees (FTE) 2025: 1.7 Unchanged (1.7) Unchanged

Key figures of APOTHEEK REYNAERTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK REYNAERTS?

What happened at APOTHEEK REYNAERTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 142,718 (▲ 76% vs 2024). Source: NBB ↗
2022 J.M.C. MANAGEMENT NV became a director. NBB
1995 CHRISTINE LAENEN became a director. NBB
Dec 1, 1984 New establishment in Scherpenheuvel-Zichem. KBO
Nov 29, 1984 Start of the company according to the CBE. KBO

In short

From € 164,239 profit in 2022 to € 142,718 profit in 2025.

Paid € 53,636 in corporate taxes since 2022.

Best year ever: 2022, with € 164,239 profit.

On average € 160,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

J.M.C. MANAGEMENT 99.6%

The stake of J.M.C. MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK REYNAERTS

Behind APOTHEEK REYNAERTS are CHRISTINE LAENEN and J.M.C. MANAGEMENT NV. The shares are held by J.M.C. MANAGEMENT (99.6%).

Directors

According to the 2025 annual accounts

CHRISTINE LAENEN

Director

Also active at: J.M.C. MANAGEMENT

since 1995

J.M.C. MANAGEMENT NV

Managing director · represented by Marc Van Rillaer

since 2022

Shareholders

J.M.C. MANAGEMENT

99.6%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Westelsebaan 61B

3271 Scherpenheuvel-Zichem

2.025.901.814

Westelsebaan 61 B

3271 Scherpenheuvel-Zichem

Active since 1 December 1984

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.518.007

VAT number

BE 0426.518.007

Registered office

Westelsebaan 61B, 3271 Scherpenheuvel-Zichem

Names & denominations

APOTHEEK REYNAERTS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

29 November 1984

Peppol

Active · Active since 18 Nov 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK REYNAERTS

Financials

What happened to APOTHEEK REYNAERTS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions